Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 18, 2015

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Viekira Pak New Drug Initial Review Require Prior Approval Prior Approval Required
Zontivity New Drug Initial Review Require Prior Approval Prior Approval Required
Harvoni New Drug Initial Review Add to Preferred Status Preferred and Require Prior Approval
Savaysa New Drug Initial Review Require Prior Approval Prior Approval Required
Grastek New Drug Initial Review Require Prior Approval Prior Approval Required
Ragwitek New Drug Initial Review Require Prior Approval Prior Approval Required
Plegridy New Drug Initial Review Require Prior Approval Prior Approval Required
Orbactiv New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required